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56 Pseudomonas aeruginosa end-stage isolates: analysis of virulence
traits and interaction with macrophages
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The airways of cystic ﬁbrosis (CF) patients are colonized by a restricted number
of bacterial species, the most common being Haemophilus inﬂuenzae, Staphylo-
coccus aureus and Pseudomonas aeruginosa. Bacterial persistence and neutrophils-
dominated inﬂammation is supposed to contribute to loss of lung function, which
ultimately can be solely resolved by lung transplantation. This is deﬁned the end
stage of CF disease and appears to be dominated by P. aeruginosa infection. Thus,
with the aim to characterize P. aeruginosa end-stage isolates, we have analyzed
some phenotypic traits of two strains isolated from CF explanted lungs, only
one of which exhibited a mucoid phenotype (Pa-M). For comparison, reference
laboratory and clinical strains were used. First, analysis of genetic diversity by
RAPD suggested that the two isolates were unrelated. Next, different virulence
factors such as motility, bioﬁlm formation and production of effectors of the type III
secretion system, were analyzed. The results obtained showed that, PaM and Pa-
nonM dampened motility, either ﬂagella- or pili-dependent, loss of ExoU secretion
and displayed a reduced capacity to form bioﬁlm on abiotic surfaces. Moreover,
mutation frequency analysis allows to categorize Pa-nonM, but not PaM, as a
mutator isolate. Additionally, in vitro infection assays of either murine or human
macrophages demonstrated that, although both isolates were killed by macrophages,
PaM survived better than Pa-nonM. Collectively, our results suggest that the winner
strategy for bacteria to persist is to dampen their virulence factors.
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Objectives: Recent studies demonstrated the impact of methicillin-resistant
Staphylococcus aureus (MRSA) on survival of CF patients. Community-acquired
MRSA (CA-MRSA) have started to replace hospital-acquired MRSA (HA-MRSA)
strains in hospital settings, and these deﬁnitions started to blur. An additional
threat for CF patients is represented by PVL-positive MRSA strains, able to cause
invasive lung infections including lung abscesses. The main goal of this study was to
assess the presence of PVL-positive MRSA strains, and to investigate their genetic
background in order to obtain a more delineated epidemiological picture.
Methods: SCCmec typing was performed according to published protocols
(Oliveira and de Lancastre, 2002), as well as Multi Locus Sequence Typing (MLST)
analysis (Enright et al, 2000). PVL genes presence was tested using a previously
published method (Lina et al, 1999).
Results: 38 MRSA strains, one/patient, median age 20.5 (range 2−48) were
screened for the presence of PVL genes. Only 1 strain infecting a 9 years-old
patient tested positive. 23 out of 38 strains (60%) belonged to HA-MRSA group,
the remaining 15 (40%) to CA-MRSA. Several epidemic lineages, such as Southern
Germany, Berlin and Archaic clone were found, while the only PVL-positive strain
belonged to ST152.
Conclusion: PVL-positive strains were described in CF population in US as well
as in Brazil, but their diffusion remains still unclear. Further studies should be
promoted to assess the epidemiology of PVL-positive MRSA strains infecting
CF patients in order to avoid their spread.
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Introduction: Recently there has been interest in the apparently increasing in-
cidence of non-tuberculous mycobacteria (NTM) in CF patients, where several
units with inadequate infection control have experienced out breaks, especially with
Mycobacterium (M) abscessus. We have adopted a strict segregation policy based
on effective microbiological surveillance for many years now at our large adult CF
unit (285 patients), and we wished to assess the incidence of NTM in our patient
population.
Method: As part of their routine annual screen and at other appropriate times, we
aim to send sputum samples from our CF patients for NTM smear and culture:
those with a positive result are then sent to the national reference laboratory for
species identiﬁcation. We interrogated our database to assess the incidence of NTM
in our clinic.
Results: Thirty-ﬁve patients (12%) do not produce sputum and were excluded: a
further 50 (19%) have not been recently tested. Of the remaining 204, 203 are smear-
negative and 104 (51%) were culture-negative: a further 75 (37%) still await ﬁnal
(negative) culture. Only 24 of those tested (12%) are culture-positive (including
the single patient who was smear-positive). Of these, 5 grew M. abscessus,
7 M. chelonae, 11 M. intracellulare, and 1 M. intracellulare//M. gordonae. Only
one patient (with M. chelonae) has had clinical deterioration since NTM infection.
Conclusions: The study has shown that we have a low incidence of NTM in
our large adult clinic, in particular with M. abscessus (2%) which has previously
been associated with poor cross infection control. We continue to conduct effective
microbiological surveillance to prevent cross-infection in our clinic.
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Objectives: To characterize a P. aeruginosa collection recovered from respiratory
samples of Spanish CF-patients included in a national multicenter study (March-
November, 2013).
Methods: 13 adult and 11 paediatric CF-Units from 17 Hospitals collected respira-
tory samples and clinical data of 15 non-selected consecutive patients during their
routinely visit. Respiratory samples were microbiologically culture using stander
CF-protocols and colonies were identiﬁed by both MALDI-TOF MS and MicroScan
System. Antibiotic susceptibility was also tested by EUCAST disk diffusion.
Genetic diversity was explored by Pulsed Field Gel Electrophoresis (PFGE) and
Multi-Locus Sequence Typing (MLST).
Results: A total of 68 P. aeruginosa isolates were obtained from 340 respira-
tory samples (20%), being more frequently recovered from adult (27.7%) than
paediatric (15.3%) patients. Antibiotic resistance rates were as follows: 67.6%
levoﬂoxacin, 52.9% gentamicin, 47.1% amikacin, 38.2% cefepime and aztreonam,
33.8% imipenem, 29.4% tobramycin, 27.9% meropenem, 25.0% ceftazidime and
13.2% piperacillin/tazobactam. Colistin was the most active compound (only 2
isolates exhibited resistance). A great genetic diversity was observed by PFGE
and MLST techniques, even inside each CF-Unit. Non-previously described alleles
were found, and new STs were assigned. The ST175 and ST111 clones, frequently
implicated in nosocomial bacteremias in Spain, were scarcely represented.
Conclusion: In Spain, lung colonization/infection by P. aeruginosa was observed in
27.7% of the adults and 15.3% of children. These isolates correspond to unrelated
genetic lineages and were multi-resistant to antibiotics.
